Data as of . Returns from exchange end-of-day prices with distributions reinvested; holdings from the fund's latest SEC filing.
XLV · State Street(R) Health Care Select Sector SPDR(R) ETF
Index equity fund · Health care
XLV is a index equity fund tracking Health care. Over the year to Sep 4, 2026 it returned +26.9% with distributions reinvested, against +20.0% for the S&P 500 and +25.6% for the Nasdaq-100. The prospectus expense ratio is 0.08% a year. By its holdings filed for Jun 30, 2026, 100% of the fund by weight is stocks the S&P 500 also holds, across 59 positions, with the top ten at 61.7%.
| What it tracks | Health care |
|---|---|
| Fund type | Index equity fund |
| Expense ratio (prospectus XBRL) | 0.08% |
| Price | $171.45 |
| Listed since | Jan 4, 2010 |
| 3 months: total return / S&P 500 / gap / Nasdaq-100 gap (ETFIQ) | +12.5% / +4.7% / +7.8 pts / +10.5 pts |
| 6 months: total return / S&P 500 / gap / Nasdaq-100 gap (ETFIQ) | +13.2% / +15.2% / −1.9 pts / −6.9 pts |
| 1 year: total return / S&P 500 / gap / Nasdaq-100 gap (ETFIQ) | +26.9% / +20.0% / +7.0 pts / +1.3 pts |
| 3 years: total return / S&P 500 / gap / Nasdaq-100 gap (ETFIQ) | +36.4% / +78.0% / −41.6 pts / −57.1 pts |
| since listing: total return / S&P 500 / gap / Nasdaq-100 gap (ETFIQ) | +618.1% / +811.4% / −193.3 pts / −1066.0 pts |
| Below its high (ETFIQ) | −2.4% |
| Holdings | 59 |
| Top ten weight | 61.7% |
| Holdings as of (SEC filing) | Jun 30, 2026 |
| Top holdings | Eli Lilly & Co 16.6%, Johnson & Johnson 10.7%, AbbVie Inc 7.8%, UnitedHealth Group Inc 6.6%, Merck & Co Inc 5.5%, Amgen Inc 3.4%, Thermo Fisher Scientific Inc 3.2%, Abbott Laboratories 2.8%, Gilead Sciences Inc 2.7%, Intuitive Surgical Inc 2.5% |
| Already in the S&P 500, by weight (ETFIQ) | 100.0% |
| Active share vs the S&P 500 (ETFIQ) | 91.1% |
| Already in the Nasdaq-100, by weight (ETFIQ) | 13.6% |
Questions people ask
- How has XLV performed?
- Over the year to Sep 4, 2026, XLV returned +26.9% with distributions reinvested, against +20.0% for the S&P 500. Over three years the figure is +36.4%.
- What does XLV cost?
- The prospectus expense ratio is 0.08% a year.
- What does XLV hold?
- 59 positions as filed for Jun 30, 2026, with the top ten at 61.7% of the fund. 100% of its weight is in stocks the S&P 500 also holds.
- How far is XLV below its high?
- 2.4% below its high of Aug 19, 2026, measured on the reinvested series to Sep 4, 2026.
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Funds near this one
Cite this page. ETFIQ, XLV, core index fund, data as of Sep 4, 2026. https://etfiq.com/funds/XLV.html Free to use with attribution; the underlying files are at Open data.
ETFIQ covers buffer, option-income and thematic ETFs. This fund is here because the desks measure against it and portfolios hold it. ETFIQ is an independent publisher and makes no recommendations. Standards and sources